Clinical trials in Groningen – page 23

557 clinical trials in Groningen, The Netherlands across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Groningen at a glance

557

clinical trials

Research sites8

Quick filters

557 trials in Groningen

Open in trial search

End stage renal disease

Not yet recruiting

A study of canagliflozin and 18F-canagliflozin in patients with chronic kidney disease undergoing dialysis

Registered drugNo placebo

A study of canagliflozin and 18F-canagliflozin in patients with chronic kidney disease undergoing dialysis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Canagliflozin
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

Squamous cell carcinoma of head and neck

Not yet recruiting

A Study Testing Cetuximab with Fluorescent Dye to Help Surgeons See Cancer Edges During Surgery in Patients with Oral Squamous Cell Carcinoma

Registered drugNo placebo

A Study Testing Cetuximab with Fluorescent Dye to Help Surgeons See Cancer Edges During Surgery in Patients with Oral Squamous Cell Carcinoma

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Cetuximab
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

Type 1 diabetes mellitus+1

Not yet recruiting

A study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease

Registered drugNo placebo

A study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease

Registered drugNo placebo

The Netherlands

Participants:18–64 years
Substances:Dapagliflozin
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

Acquired ATTR amyloidosis

Not yet recruiting

A Study of Acoramidis for Long-Term Safety in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy

InvestigationalNo placebo

A Study of Acoramidis for Long-Term Safety in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Acoramidis Hydrochloride
Sponsor:Eidos Therapeutics Inc.

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Study on Extending Osimertinib Dosing for Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

Study on Extending Osimertinib Dosing for Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Osimertinib
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Squamous cell carcinoma of head and neck

Not yet recruiting

Study on Imaging Head and Neck Cancer Using [18F]-Olaparib for Patients with Squamous Cell Carcinoma

InvestigationalNo placebo

Study on Imaging Head and Neck Cancer Using [18F]-Olaparib for Patients with Squamous Cell Carcinoma

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Olaparib
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

Thyroid mass+4

Not yet recruiting

Study Comparing Radiofrequency Ablation and Sodium Iodide (131I) for Treating Hyperthyroidism in Patients with Overactive Thyroid Nodules

Registered drugNo placebo

Study Comparing Radiofrequency Ablation and Sodium Iodide (131I) for Treating Hyperthyroidism in Patients with Overactive Thyroid Nodules

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Sodium Iodide (131I)
Sponsor:Rijnstate Ziekenhuis Stichting

Contact Research Centre

Staphylococcal infection+1

Not yet recruiting

Study of PP1493 and PP1815 phage therapy for patients with knee or hip joint infections caused by Staphylococcus aureus after prosthetic surgery

Registered drug

Study of PP1493 and PP1815 phage therapy for patients with knee or hip joint infections caused by Staphylococcus aureus after prosthetic surgery

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Pp1493

Contact Research Centre

Study on Heparin and Nadroparin Calcium for Patients Undergoing ECMO Treatment to Reduce Bleeding Risks

Not yet recruiting

Registered drugNo placebo

Study on Heparin and Nadroparin Calcium for Patients Undergoing ECMO Treatment to Reduce Bleeding Risks

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Heparin
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

Cerebral amyloid angiopathy+2

Not yet recruiting

Study of [18F]MC225 to Assess P-glycoprotein Function in Patients with Alzheimer's, Mild Cognitive Impairment, and Parkinson's Disease

InvestigationalNo placebo

Study of [18F]MC225 to Assess P-glycoprotein Function in Patients with Alzheimer's, Mild Cognitive Impairment, and Parkinson's Disease

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:[18F]Mc225
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

Still's disease+1

Not yet recruiting

Study on Anakinra for Children with Systemic Juvenile Idiopathic Arthritis

Registered drugNo placebo

Study on Anakinra for Children with Systemic Juvenile Idiopathic Arthritis

Registered drugNo placebo

The Netherlands

Participants:0–17 years
Substances:Anakinra
Sponsor:Universitair Medisch Centrum Utrecht

Contact Research Centre

Pancreatic carcinoma

Not yet recruiting

Study of perioperative versus post-surgery FOLFIRINOX (irinotecan, oxaliplatin, fluorouracil, and folinic acid) treatment in patients with resectable pancreatic cancer

Registered drugNo placebo

Study of perioperative versus post-surgery FOLFIRINOX (irinotecan, oxaliplatin, fluorouracil, and folinic acid) treatment in patients with resectable pancreatic cancer

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Fluorouracil
Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Groningen

What the registry says about research in the country

01 Cardiovascular Research

Advanced studies focusing on heart disease and cardiovascular conditions, including innovative treatments for ATTR amyloidosis and prevention strategies for heart failure.

Cardiomyopathy Treatments
Heart Failure Prevention
Peripheral Arterial Disease

Multiple trials exploring novel therapeutic approaches and preventive measures for various cardiac conditions.

02 Oncology Studies

Comprehensive research into various cancer types, including melanoma and lung cancer, with particular focus on innovative treatment approaches and metastatic disease management.

Advanced Breast Cancer
Small Cell Lung Cancer
Brain Metastases

Investigation of targeted therapies and combination treatments for improved patient outcomes.

03 Metabolic Disorders

Clinical investigations focusing on obesity and type 2 diabetes, testing new therapeutic approaches for weight management and metabolic control.

Weight Management
Diabetes Treatment
Metabolic Health

Evaluation of novel medications combined with lifestyle interventions for optimal patient care.

Back to the Netherlands All countries